アプリケーションノート：バリデーションに対応した次世代シーケンス（NGS）ワークフローによるバイオセーフティー試験

Biosafety testing is critical in biopharma R&D to ensure product integrity, safeguard patient health, and meet stringent regulatory standards. Next-generation sequencing (NGS)-based assays have become a game-changer in biosafety testing, offering unmatched sensitivity and accuracy. However, their implementation presents challenges, including managing complex data workflows, handling large datasets, generating regulatory-compliant reporting, and the need for bioinformatics expertise. 

Genedata Selector^® is an off-the-shelf, digital solution that addresses these challenges and converts data into actionable results for all NGS-based biosafety assays. A sequencing technology-agnostic platform, it is designed to streamline sample and data management while providing automated analysis and intuitive visualization. Powered by Playbooks, wizard-based guides, Genedata Selector integrates seamlessly into GMP environments, providing a single source of truth for comprehensive reporting, internal documentation, and regulatory submissions.